Orchid Chemicals & Pharmaceuticals has informed that the Allotment Committee of the Board of Directors at their meeting held on December 22, 2014 has allotted 1,48,09,801 equity shares of Rs. 10/- each @ Rs. 49.79/- (including a premium of Rs. 39.79/- per share) as the first tranche to the Promoter group Company M/s Orchid Healthcare Private Limited on Preferential Basis as per the Corporate Debt Restructuring (CDR) Scheme approved by the CDR Empowered Group in terms of CDR Scheme.
The above information is a part of company’s filings submitted to BSE.
